Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001012477-25-000031
Filing Date
2025-11-04
Accepted
2025-11-04 16:11:56
Documents
76
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q avdl-20250930.htm   iXBRL 10-Q 1223755
2 EX-10.2 exhibit102q32025.htm EX-10.2 244725
3 EX-10.3 exhibit103q32025.htm EX-10.3 146620
4 EX-31.1 exhibit311q32025.htm EX-31.1 10668
5 EX-31.2 exhibit312q32025.htm EX-31.2 10477
6 EX-32.1 exhibit321q32025.htm EX-32.1 5625
7 EX-32.2 exhibit322q32025.htm EX-32.2 5461
  Complete submission text file 0001012477-25-000031.txt   6460641

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT avdl-20250930.xsd EX-101.SCH 38803
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT avdl-20250930_cal.xml EX-101.CAL 66039
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT avdl-20250930_def.xml EX-101.DEF 143173
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT avdl-20250930_lab.xml EX-101.LAB 507451
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT avdl-20250930_pre.xml EX-101.PRE 341454
78 EXTRACTED XBRL INSTANCE DOCUMENT avdl-20250930_htm.xml XML 791809
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address 10 EARLSFORT TERRACE DUBLIN 2 Ireland D02 T380 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37977 | Film No.: 251449157
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)